GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: BLK
Buy $360

Blackrock, Inc. (NYSE: BLK) reiterated to Buy with price target $360 by Argus

Monday,  Jan 18, 2016  8:25 AM ET by Lynn Gilbert

Argus reiterated Blackrock, Inc. (NYSE: BLK) to Buy with price target $360.
Previously, Argus rated Blackrock, Inc. (NYSE: BLK) to Buy with price target $360 on 01/15/2016, when the stock price was valued at $298.41.

BlackRock, Inc. (BlackRock) operates as an investment management firm in the United States. As of December 31, 2008, the Company had $1.307 trillion of assets under management (AUM). BlackRock provides diversified investment management services to institutional clients and to individual investors through various investment vehicles. Its investment management services primarily consist of the active management of fixed income, cash management and equity client accounts; the management of a number of open-end and closed-end mutual fund families, and other non-United States equivalent retail products serving the institutional and retail markets, and the management of alternative funds developed to serve various customer needs. In addition, BlackRock provides market risk management, financial markets advisory and enterprise investment system services to a broad base of clients. In December 2009, the Company completed its merger with Barclays Global Investors.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy